REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Optimapharm d.o.o. (Croatia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Optimapharm d.o.o. Profile Updated: September 04, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Optimapharm d.o.o. is an enterprise in Croatia, with the main office in Zagreb. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. 57 (2022) employees currently work for Optimapharm d.o.o.. The company’s latest financial report indicates a net sales revenue increase of 18.15% in 2022. Its’ total assets recorded a growth of 2.75%. The enterprise’s net profit margin decreased by 9.7% in 2022.

Headquarters
Grada Vukovara 284 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Optimapharm d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Optimapharm d.o.o. report to view the information.
Outstanding Shares:
Purchase the Optimapharm d.o.o. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
President of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Optimapharm d.o.o.
Company Performance
Financial values in the chart are available after Optimapharm d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.15%▲
Total operating revenue
18.15%▲
Operating profit (EBIT)
79.74%▲
EBITDA
45.96%▲
Net Profit (Loss) for the Period
-177.83%▼
Total assets
2.75%▲
Total equity
-14.88%▼
Operating Profit Margin (ROS)
6.06%▲
Net Profit Margin
-9.7%▼
Return on Equity (ROE)
-12.13%▼
Debt to Equity Ratio
48.72%▲
Quick Ratio
-0.12%▼
Cash Ratio
-0.07%▼

Similar companies

Selvita d.o.o.
 
Inetec-Institut Za Nuklearnu Tehnologiju d.o.o.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo